Hypolipidemic drugs and lipoprotein metabolism
Levy, R.I.; Langer, T.
Advances in Experimental Medicine and Biology 26(0): 155-163
1972
ISSN/ISBN: 0065-2598 PMID: 4370081 Document Number: 56854
Document emailed within 1 workday
Related Documents
Staels, B.; Van Tol, A.; Fruchart, J.C.; Auwerx, J. 1996: Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat Israel Journal of Medical Sciences 32(6): 490-498Packard, C.J.; Shepherd, J. 1982: Drugs and high density lipoprotein metabolism Health Bulletin 40(6): 310-316
Oms, P.; Bruniquel, F.; Puech, L.; Delhon, A. 1992: Effects of the new hypolipidemic agent F 2833 on plasma lipoprotein levels in normal and hyperlipidemic hamsters Methods and Findings in Experimental and Clinical Pharmacology 14(7): 531-535
Enzi, G.; Martini, S.; Baggio, G.; Baldo, G.; Digito, M.; Zanella, A. 1985: Lipoprotein metabolism in patients with elevated lipoprotein-lipase activity in adipose tissue International Journal of Obesity 9(Suppl 1): 173-176
Cagli, V. 1971: Hypolipidemic drugs Professioni Infermieristiche 24(5): 145-146
Maffei Facino, R.; Carini, M.; Tofanetti, O. 1986: Metabolism of the hypolipidemic agent tiadenol in man and in the rat Arzneimittel-Forschung 36(4): 722-728
Tamachi, H.; Goto, Y. 1988: Progress in the study of lipoprotein metabolism and atherosclerosis: organ-specific characteristics of lipoprotein metabolic disorders--with special reference to the heart and brain Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 671-678
Svoboda, D.J.; Azarnoff, D.L. 1971: Effects of selected hypolipidemic drugs on cell ultrastructure Federation Proceedings 30(3): 841-847
Masquelier, M.; Vitols, S.; Peterson, C. 1986: Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice Cancer Research 46(8): 3842-3847
David, A.; Rozé, C.; Chariot, J.; Hollande, E. 1979: Nucleic acid content of hepatic cells during experimental hepatomegalies induced by hypolipidemic drugs in rats Gastroenterologie Clinique et Biologique 3(11): 821-829
Moody, D.E.; Reddy, J.K. 1974: Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate Research Communications in Chemical Pathology and Pharmacology 9(3): 501-510
1997: Medical recommendations and references about hypolipidemic drugs. ANDEM (National Agency for the Development of Medical Evaluation Journal des Maladies Vasculaires 22(4): 249-264
Kurashvili, L.V. 1986: Lipoprotein metabolism in burns Klinicheskaia Meditsina 64(9): 109-111
Packard, C.J.; Sheperd, J. 1988: Receptors in the regulation of lipoprotein metabolism Annales de Biologie Clinique 46(1): 5-9
Ahumada Ayala, M. 1991: Disorders of lipoprotein metabolism. I. the physiopathology Archivos del Instituto de Cardiologia de Mexico 61(1): 79-91
Deshaies, Y. 1989: Dietary protein and lipoprotein metabolism Nutrition 5(4): 293
Audet, A.; Lupien, P.J. 1972: Lipoprotein metabolism in pyridoxine deficiency Revue Canadienne de Biologie 31(3): 171-180
Yoshioka, T.; Motoyama, H.; Yamasaki, F. 1986: Lipid and lipoprotein metabolism in the pregnant rat Nihon Sanka Fujinka Gakkai Zasshi 38(3): 311-316
Forrest, I.S.; Green, D.E.; Blum, A.; Serra, M.T.; Loeffler, K.O. 1979: Studies on thioridazine and mesoridazine metabolism. II. in vivo metabolism of tritiated drugs in rhesus monkeys Communications in Psychopharmacology 3(5): 323-327
Tonge, S.R.; Leonard, B.E. 1972: Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism Archives Internationales de Pharmacodynamie et de Therapie 195(1): 168-176